// App-Quantinova.ai

4579 : Simultaneous activation of C-X-C chemokine receptor 4 and cannabinoid receptor 2 results in decreased cell signaling and tumor cell intravasation

Researchers

Presenter

  • Imani N. Fennell

Principal Investigators

  • Kisha A. Scarlett

  • Christopher J. Coke

Medical Centers

  • Spelman College, Atlanta, GA.

  • Clark Atlanta University, Atlanta, GA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • C-X-C motif chemokine receptor 4

  • Matrix metallopeptidase 9

  • Matrix metalloproteinase 2

Drug/Treatment

  • CXCL12

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved